Advanced Ovarian Cancer: Platinum Sensitive
Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
Cancer Types: Ovarian
Lines of Therapy: 3rd Line+ Metastatic